ACETYLDIGOXIN

Acetyldigoxin is a semisynthetic cardiac glycoside that enhances cardiac output via Na⁺/K⁺‑ATPase inhibition. Used for heart failure and atrial arrhythmias, it offers predictable absorption. Risks include arrhythmias, GI upset, fatigue, and toxicity, especially in renal impairment.

SKU: 170fde3d3d02 Category: Tag:

Product Description


Mechanism of action

Acetyldigoxin is a semi‑synthetic derivative of digoxin in which an acetyl group is introduced to modify pharmacokinetic behaviour. Like digoxin, it inhibits the myocardial sodium–potassium ATPase pump, increasing intracellular calcium and producing a positive inotropic effect while also influencing autonomic tone at the atrioventricular node.

Benefits and advantages

Acetyldigoxin has been used as an alternative oral cardiac glycoside with slightly different absorption and distribution characteristics compared with digoxin. It can be formulated to achieve more predictable plasma levels in some patients and is of interest for comparative pharmacology and generic development.

Side effects and risks

Adverse effects are similar to those of other digitalis glycosides and include nausea, vomiting, anorexia, dizziness, confusion and a spectrum of brady- and tachyarrhythmias that may be life‑threatening. The risk is heightened by renal impairment, electrolyte imbalance or interacting drugs. The raw material should therefore be handled only in specialised facilities with appropriate containment.

Datasheet


Molecular Formula

C43H66O15

Molecular Weight

823.0 g/mol

CAS Number

5511-98-8

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance.

Purity

Purity information is available upon request (COA).

Synonym

alpha-Acetyldigoxin; 5511-98-8; Acetyldigoxin; Lanatilin; Sandolanid

IUPAC/Chemical Name

[(2R,3R,4S,6S)-6-[(2R,3S,4S,6S)-6-[(2R,3S,4S,6R)-6-[[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-12,14-dihydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2-methyloxan-3-yl]oxy-3-hydroxy-2-methyloxan-4-yl] acetate

InChl Key

HWKJSYYYURVNQU-DXJNJSHLSA-N

InChl Code

InChI=1S/C43H66O15/c1-20-38(49)32(55-23(4)44)18-37(52-20)58-40-22(3)54-36(17-31(40)46)57-39-21(2)53-35(16-30(39)45)56-26-9-11-41(5)25(14-26)7-8-28-29(41)15-33(47)42(6)27(10-12-43(28,42)50)24-13-34(48)51-19-24/h13,20-22,25-33,35-40,45-47,49-50H,7-12,14-19H2,1-6H3/t20-,21-,22-,25-,26+,27-,28-,29+,30+,31+,32+,33-,35+,36+,37+,38-,39-,40-,41+,42+,43+/m1/s1

References

https://pubchem.ncbi.nlm.nih.gov/compound/11765960;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download